India wants Serum Institute to lower price of AstraZeneca's Covid-19 vaccine

Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot, one of the sources said. Serum chief executive Adar Poonawalla had said in November the vaccine would be priced at about Rs 1,000 per dose for the private market in India and would cost the government about Rs 250 per dose.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news